SCHEMBL19080077

SCHEMBL19080077

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7c(c6)c6ccccc6c6c7oc7c8ccccc8c8ccccc8c76)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
ARSA P15289 1/20 0.36
CDC25A P30304 1/20 0.36
CDC25C P30307 1/20 0.36
SOS1 Q07889 1/20 0.35
ALDH1A1 P00352 3/20 0.34
CYP1A2 P05177 2/20 0.34
HSD17B10 Q99714 2/20 0.34
PIM1 P11309 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.34
PRKDC P78527 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080073 0.94 CYP1A1 (0.41) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080068 0.93 CYP1A1 (0.35) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19079969 0.92 CA12 (0.36) ARSACDC25ACDC25CSOS1ALDH1A1
SCHEMBL19079982 0.91 CA12 (0.36) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL17944572 0.91 ALOX5 (0.38) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080076 0.90 CYP1A1 (0.41) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080071 0.90 SOS1 (0.34) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080114 0.90 CYP1A1 (0.43) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080093 0.89 CYP1A1 (0.39) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080061 0.88 MCL1 (0.38) ARSACDC25ACDC25CSOS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ARSA 4452/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ARSA 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.